$MLRT
Metalert, Inc. Stock $mlrt

$mlrt Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000149315223029426 Filed on August 18, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$85.74K	$48.84K	$64.40K
YoY Change	26.74%	-24.17%	-59.65%
Cost Of Revenue	$85.66K	$43.31K	$41.96K
YoY Change	225.11%	3.22%	-13.16%
Gross Profit	$77.00	$5.526K	$22.44K
YoY Change	-99.81%	-75.37%	-79.84%
Gross Profit Margin	0.09%	11.31%	34.84%
Selling, General & Admin	$70.60K	$178.5K	$32.35K
YoY Change	-1.62%	451.72%	-68.11%
% of Gross Profit	91693.51%	3229.82%	144.16%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$8.340K	$8.330K	$8.330K
YoY Change		0.0%	1442.59%
% of Gross Profit	10831.17%	150.74%	37.12%
Operating Expenses	$253.5K	$186.8K	$240.9K
YoY Change	-9.95%	-22.43%	-24.59%
Operating Profit	-$253.4K	-$181.3K	-$218.4K
YoY Change	5.5%	-17.0%	4.95%
Interest Expense	-$155.2K		-$1.500K
YoY Change			-96.83%
% of Operating Profit
Other Income/Expense, Net	-$176.2K	-$27.29K	-$7.813K
YoY Change	182.86%	249.33%	-83.51%
Pretax Income	-$429.6K	-$208.6K	-$226.2K
YoY Change		-7.8%	-11.46%
Income Tax
% Of Pretax Income
Net Earnings	-$429.6K	-$208.6K	-$226.2K
YoY Change	42.02%	-7.8%	-11.45%
Net Earnings / Revenue	-501.0%	-427.08%	-351.27%
Basic Earnings Per Share	-$0.02	-$0.02	$0.00
Diluted Earnings Per Share	-$0.02	-$0.02	-$920.60
COMMON SHARES
Basic Shares Outstanding	23.52M shares	22.83M shares	245.7M shares
Diluted Shares Outstanding	25.84M shares	22.90M shares	3.780M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$107.0K	$45.74K	$62.33K
YoY Change		-26.62%	-85.59%
Cash & Equivalents	$106.3K	$45.09K	$61.14K
Short-Term Investments	$650.00	$650.00	$1.190K
Other Short-Term Assets	$4.769K	$4.770K	$22.27K
YoY Change	-73.25%	-78.58%	-87.62%
Inventory	$256.6K	$56.46K	$80.52K
Prepaid Expenses
Receivables	$62.14K	$12.92K	$9.140K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$430.5K	$119.9K	$174.3K
YoY Change	173.79%	-31.2%	-77.69%
LONG-TERM ASSETS
Property, Plant & Equipment	$34.12K	$42.45K	$75.79K
YoY Change	-49.43%	-43.99%	7.28%
Goodwill
YoY Change
Intangibles	$279.5K	$3.308K
YoY Change	8348.16%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$313.6K	$45.76K	$75.79K
YoY Change	343.13%	-39.63%	7.28%
TOTAL ASSETS
Total Short-Term Assets	$430.5K	$119.9K	$174.3K
Total Long-Term Assets	$313.6K	$45.76K	$75.79K
Total Assets	$744.1K	$165.7K	$250.1K
YoY Change	226.35%	-33.75%	-70.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$205.9K	$165.2K	$122.3K
YoY Change	61.87%	35.11%	-26.83%
Accrued Expenses	$277.0K	$226.4K	$345.8K
YoY Change	-17.08%	-34.54%	27.32%
Deferred Revenue	$6.450K	$6.550K	$19.10K
YoY Change	-59.62%	-65.71%	-39.17%
Short-Term Debt	$2.805M	$2.539M	$1.780M
YoY Change		42.62%	10.12%
Long-Term Debt Due	$111.2K	$111.2K	$37.35K
YoY Change		197.62%	433.57%
Total Short-Term Liabilities	$4.161M	$3.734M	$3.158M
YoY Change	30.91%	18.26%	5.46%
LONG-TERM LIABILITIES
Long-Term Debt	$138.3K	$139.6K	$144.7K
YoY Change		-3.51%	-33.61%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$138.3K	$139.6K	$144.7K
YoY Change		-3.51%	-33.61%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.161M	$3.734M	$3.158M
Total Long-Term Liabilities	$138.3K	$139.6K	$144.7K
Total Liabilities	$4.300M	$3.874M	$3.302M
YoY Change	29.43%	17.31%	2.81%
SHAREHOLDERS EQUITY
Retained Earnings	-$28.44M	-$28.01M	-$26.47M
YoY Change	6.23%	5.82%	4.23%
Common Stock	$3.187K	$2.341K	$24.71K
YoY Change	104.82%	-90.53%	15.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.555M	-$3.708M	-$3.052M
YoY Change
Total Liabilities & Shareholders Equity	$744.1K	$165.7K	$250.1K
YoY Change	226.35%	-33.75%	-70.64%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$429.6K	-$208.6K	-$226.2K
YoY Change	42.02%	-7.8%	-11.45%
Depreciation, Depletion And Amortization	$8.340K	$8.330K	$8.330K
YoY Change		0.0%	1442.59%
Cash From Operating Activities	-$139.4K	-$106.5K	-$128.0K
YoY Change		-16.79%	-23.18%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$42.41K	$0.00	$0.00
YoY Change
Cash From Investing Activities	$42.41K	$0.00	$0.00
YoY Change			-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	158.2K	146.9K	144.2K
YoY Change		1.86%	-41.29%
NET CHANGE
Cash From Operating Activities	-139.4K	-106.5K	-128.0K
Cash From Investing Activities	42.41K	0.000	0.000
Cash From Financing Activities	158.2K	146.9K	144.2K
Net Change In Cash	61.24K	40.42K	16.24K
YoY Change		148.89%	-22.74%
FREE CASH FLOW
Cash From Operating Activities	-$139.4K	-$106.5K	-$128.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001375793
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2023Q2	us-gaap	Other Liability Current Related Party Type Extensible Enumeration OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Other Liability Current Related Party Type Extensible Enumeration OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense		usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q2	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss		usd
CY2023Q2	MLRT	Grant From Care Loans GrantFromCareLoans		usd
CY2022Q2	MLRT	Grant From Care Loans GrantFromCareLoans		usd
	MLRT	Grant From Care Loans GrantFromCareLoans		usd
CY2023Q2	us-gaap	Interest Expense InterestExpense		usd
CY2022Q2	us-gaap	Interest Expense InterestExpense		usd
	us-gaap	Interest Expense InterestExpense		usd
	us-gaap	Interest Expense InterestExpense		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	MLRT	Grant From Care Loans GrantFromCareLoans		usd
	MLRT	Gains Losses On Settlement Of Debt And Accrued Interest GainsLossesOnSettlementOfDebtAndAccruedInterest		usd
	MLRT	Gain On Extinguishment Of Debt GainOnExtinguishmentOfDebt		usd
	MLRT	Increase Decrease In Account Payable And Financing Costs IncreaseDecreaseInAccountPayableAndFinancingCosts		usd
	us-gaap	Increase Decrease In Due To Officers And Stockholders Current IncreaseDecreaseInDueToOfficersAndStockholdersCurrent		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments		usd
	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		usd
	MLRT	Debt Discount On Convertible Notes DebtDiscountOnConvertibleNotes		usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization		usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization		usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent		usd
CY2023Q2	MLRT	Paycheck Protection Program Loan Amount PaycheckProtectionProgramLoanAmount		usd
CY2022Q4	MLRT	Paycheck Protection Program Loan Amount PaycheckProtectionProgramLoanAmount		usd
	MLRT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-53046
	dei	Entity Registrant Name EntityRegistrantName	MetAlert, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0493446
	dei	Entity Address Address Line1 EntityAddressAddressLine1	117 W. 9th Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1214
	dei	Entity Address City Or Town EntityAddressCityOrTown	Los Angeles
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90015
	dei	City Area Code CityAreaCode	(213)
	dei	Local Phone Number LocalPhoneNumber	489-3019
	dei	Security12b Title Security12bTitle	Common Stock, Par Value $0.0001
	dei	Trading Symbol TradingSymbol	MLRT
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23521342	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45089	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8534	usd
CY2023Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	12921	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	13959	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	56464	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	70112	usd
CY2023Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	649	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	683	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	4770	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	8045	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	119893	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	101333	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3308	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3308	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	42450	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	59121	usd
CY2023Q2	us-gaap	Assets Assets	165651	usd
CY2022Q4	us-gaap	Assets Assets	163762	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	165197	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	137315	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	226371	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	388414	usd
CY2023Q2	MLRT	Accrued Expenses Related Parties Current AccruedExpensesRelatedPartiesCurrent	686155	usd
CY2022Q4	MLRT	Accrued Expenses Related Parties Current AccruedExpensesRelatedPartiesCurrent	497551	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	6550	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	12850	usd
CY2023Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	100741	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	81651	usd
CY2023Q2	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	10417	usd
CY2022Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	7903	usd
CY2023Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1173778	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	843000	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1173956	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1206738	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	146195	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	149120	usd
CY2023Q2	MLRT	Notes Payable Related Parties NotesPayableRelatedParties	45000	usd
CY2022Q4	MLRT	Notes Payable Related Parties NotesPayableRelatedParties	10000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3734360	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3334542	usd
CY2023Q2	us-gaap	Long Term Loans Payable LongTermLoansPayable	139583	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	142097	usd
CY2023Q2	us-gaap	Liabilities Liabilities	3873943	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3476639	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2071000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2071000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23411342	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23411342	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17179794	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17179794	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	2341	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1718	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24303554	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24241862	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-28014201	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27556471	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-3708292	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3312877	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	165651	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	163762	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	48839	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	64402	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	121532	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	232917	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	43313	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	41962	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	73680	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	136825	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	5526	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	22440	usd
	us-gaap	Gross Profit GrossProfit	47852	usd
	us-gaap	Gross Profit GrossProfit	96092	usd
CY2023Q2	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	118849	usd
CY2022Q2	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	131323	usd
	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	242494	usd
	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	255088	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	20399	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	77177	usd
	us-gaap	Professional Fees ProfessionalFees	51923	usd
	us-gaap	Professional Fees ProfessionalFees	175339	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5058	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	-20	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	15599	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	47569	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	27292	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	113458	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	88399	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	186817	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	240850	usd
	us-gaap	Operating Expenses OperatingExpenses	407855	usd
	us-gaap	Operating Expenses OperatingExpenses	534425	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-181291	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-218410	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-360003	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-438333	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	44217	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	44217	usd
CY2022Q2	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-180	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-34	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-1275	usd
CY2023Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	21165	usd
CY2022Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6316	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	42219	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	12563	usd
	MLRT	Grant From Care Loans GrantFromCareLoans	67870	usd
CY2023Q2	MLRT	Interest Expense Income And Financing Costs InterestExpenseIncomeAndFinancingCosts	-50345	usd
CY2022Q2	MLRT	Interest Expense Income And Financing Costs InterestExpenseIncomeAndFinancingCosts	-1317	usd
	MLRT	Interest Expense Income And Financing Costs InterestExpenseIncomeAndFinancingCosts	-99691	usd
	MLRT	Interest Expense Income And Financing Costs InterestExpenseIncomeAndFinancingCosts	-36307	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-27293	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7813	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-97727	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	17725	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-208584	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-226223	usd
	us-gaap	Net Income Loss NetIncomeLoss	-457730	usd
	us-gaap	Net Income Loss NetIncomeLoss	-420608	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-208584	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-226223	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-457730	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-420608	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22896968	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22896968	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3780289	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3780289	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22096739	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22096739	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3702136	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3702136	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22896968	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3780289	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22096739	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3702136	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-3505487	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	5779	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-208584	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-3708292	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-3009406	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	33326	usd
CY2022Q2	MLRT	Issuance Of Common Stock For Conversion Of Warrants One IssuanceOfCommonStockForConversionOfWarrantsOne	150000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-226223	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-3052303	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3312877	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	62315	usd
	us-gaap	Net Income Loss NetIncomeLoss	-457730	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-3708292	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2879621	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2879621	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	72926	usd
	MLRT	Issuance Of Common Stock For Financings IssuanceOfCommonStockForFinancings	150000	usd
	MLRT	Issuance Of Common Stock For Conversion Of Warrants IssuanceOfCommonStockForConversionOfWarrants	25000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-420608	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-3052303	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-3052303	usd
	us-gaap	Net Income Loss NetIncomeLoss	-457730	usd
	us-gaap	Net Income Loss NetIncomeLoss	-420608	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	16670	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	16670	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-34	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-1275	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	72926	usd
	MLRT	Grant From Care Loans GrantFromCareLoans	67870	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	42219	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	12563	usd
	MLRT	Gains Losses On Settlement Of Debt And Accrued Interest GainsLossesOnSettlementOfDebtAndAccruedInterest	-27537	usd
	MLRT	Gain On Extinguishment Of Debt GainOnExtinguishmentOfDebt	-16680	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1038	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4592	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-13647	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-17740	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-3275	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-32743	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	113980	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2539	usd
	MLRT	Increase Decrease In Account Payable Related Parties IncreaseDecreaseInAccountPayableRelatedParties	132654	usd
	MLRT	Increase Decrease In Account Payable Related Parties IncreaseDecreaseInAccountPayableRelatedParties	75883	usd
	MLRT	Increase Decrease In Account Payable And Financing Costs IncreaseDecreaseInAccountPayableAndFinancingCosts	-94518	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-6300	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-18150	usd
	us-gaap	Increase Decrease In Due To Officers And Stockholders Current IncreaseDecreaseInDueToOfficersAndStockholdersCurrent	35000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-155814	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-269697	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	46881	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	34180	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	150000	usd
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	25000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	25000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	190000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	7510	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	27791	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	9180	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	16722	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	25000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	192368	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	192490	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	36554	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-77207	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8535	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	138342	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	45089	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	61135	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	62315	usd
	MLRT	Debt Discount On Convertible Notes DebtDiscountOnConvertibleNotes	7150	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-3708292	usd
CY2023Q2	MLRT	Working Capital WorkingCapital	3614467	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	121532	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	232917	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	121532	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	232917	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	12431	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	12431	usd
	us-gaap	Standard Product Warranty Description StandardProductWarrantyDescription	The Company’s warranty policy provides repair or replacement of products (excluding GPS Shoe devices) returned for defects within ninety days of purchase
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_zPfwooNf1naa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_866_zzBMqgRQLqf5">Use of Estimates</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the accompanying unaudited financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates include, but are not limited to, estimates related to revenue recognition, allowance for doubtful accounts, inventory valuation, tangible and intangible long-term asset valuation, warranty and other obligations and commitments. Estimates are updated on an ongoing basis and are evaluated based on historical experience and current circumstances. Changes in facts and circumstances in the future may give rise to changes in these estimates which may cause actual results to differ from current estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zuGLzwY5T16b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_864_zb8lJOXjnRak">Concentrations</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We currently rely on one manufacturer to supply us with our GPS SmartSole and one manufacturer to supply us with the GPS device included in the GPS SmartSole. The loss of either of these manufacturers could severely impede our ability to manufacture the GPS SmartSole.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, the Company had four customers representing approximately <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zEVE4YGRbSrj">29</span>%, <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zypavAn8vgPg">29</span>%, <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zgWNAxd9J3d2">15</span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerFourMember_zRokm9v27VE4">14</span>% of sales, respectively, and three customers representing approximately <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zwbXMp1OAhj6">14</span>%, <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zZncUEBB8V14">8</span>%, and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zGDMFPiqxjwk">7</span>% of total accounts receivable, respectively. As of June 30, 2022, the Company had four customers representing approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220630__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z6W6Tgpnj5Z5">38</span>%, <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zpwvbYFQx5Db">14</span>%, <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_ztrpE4wXIBk7">10</span>% and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerFourMember_zonCpXcz4xxf">9</span>% of sales, respectively (of the <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OnlineStoreMember_z5shuxl0Wey2">38</span>% in receivables represents, this represents sales made through our online store and consists of approximately 2,000 different customers), and four customers representing approximately <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z0eWmFO8hi8i">23</span>%, <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_z4yYP8pXAv65">7</span>%, <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zNFsi2vb0Jab">7</span>% and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zPygZpV4Hw71">6</span>% of total accounts receivable, respectively (excluding related party payables).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	649	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	683	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	603846	shares
CY2023Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2023Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	89040381	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	73386627	shares
	MLRT	Investment Owned Description InvestmentOwnedDescription	The Company’s investments in marketable securities is comprised of shares of stock of two (2) entities with ownership percentages of less than 5%. The Company accounted for these investments pursuant to ASU 320, Investments – Debt and Equity Securities. As such, these investments were recorded at their market value as of December 31, 2019, with the change in fair value being reflected in the statement of operations
	MLRT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice	0.05
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	300000	shares
	MLRT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expired In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice	0.975
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations	157692	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	746154	shares
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	37286	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	51531	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	19178	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	18581	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	56464	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	70112	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	471584	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	454913	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	42450	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	59121	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3308	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3308	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3308	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3308	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	146195	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	149120	usd
CY2023Q2	us-gaap	Line Of Credit LineOfCredit	100741	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	7000	usd
CY2023Q2	us-gaap	Other Borrowings OtherBorrowings	10417	usd
CY2022Q4	us-gaap	Other Borrowings OtherBorrowings	74651	usd
CY2023Q2	us-gaap	Notes Payable NotesPayable	257353	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	230771	usd
CY2022Q2	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	25000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	120000	usd
CY2023Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	998428	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	843000	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	7150	usd
CY2023Q2	us-gaap	Convertible Debt ConvertibleDebt	998428	usd
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	843000	usd
CY2023Q2	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	10417	usd
CY2022Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	7903	usd
CY2023Q2	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm	139583	usd
CY2022Q4	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm	142097	usd
CY2023Q2	MLRT	Short Term And Long Term Loans Payable ShortTermAndLongTermLoansPayable	150000	usd
CY2022Q4	MLRT	Short Term And Long Term Loans Payable ShortTermAndLongTermLoansPayable	150000	usd
CY2022Q1	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	68870	usd
CY2021	MLRT	Due To Related Parties Amount Converted Into Notes DueToRelatedPartiesAmountConvertedIntoNotes	200000	usd
CY2023Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2020Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	7604762	shares
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	72926	usd
	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-65 reverse stock split
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023Q2	MLRT	Bonus Declared Or Accrued BonusDeclaredOrAccrued	0	usd
CY2022Q4	MLRT	Bonus Declared Or Accrued BonusDeclaredOrAccrued	0	usd

Files In Submission

Name	View Source	Status
mlrt-20230630_cal.xml	Edgar Link	unprocessable
0001493152-23-029426-index-headers.html	Edgar Link	pending
0001493152-23-029426-index.html	Edgar Link	pending
0001493152-23-029426.txt	Edgar Link	pending
0001493152-23-029426-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mlrt-20230630.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
mlrt-20230630_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
mlrt-20230630_def.xml	Edgar Link	unprocessable
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mlrt-20230630_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MLRT
Metalert, Inc. Stock $mlrt

2023 Q3 Form 10-Q Financial Statement

#000149315223029426 Filed on August 18, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLRT Metalert, Inc. Stock $mlrt

2023 Q3 Form 10-Q Financial Statement

#000149315223029426 Filed on August 18, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLRT
Metalert, Inc. Stock $mlrt